Yolanda Sanchez
About Yolanda Sanchez
Yolanda Sanchez is an experienced biologist currently serving as the Interim Head of Biology, with over 25 years of expertise in translational research and drug discovery.
Interim Head of Biology
Yolanda Sanchez currently serves as the Interim Head of Biology. In this role, she oversees various biological research activities. Her primary responsibilities include guiding research projects, mentoring team members, and ensuring the overall quality and direction of biological studies. Her position requires a comprehensive understanding of biological research methodologies and the ability to lead a diverse team of researchers and scientists.
25+ Years in Translational Research and Drug Discovery
Yolanda Sanchez brings over 25 years of experience in translational research and drug discovery. Her extensive background in this field encompasses numerous aspects of the drug development process, from identifying and validating targets and pathways to optimizing leads and selecting candidates. Additionally, Sanchez is well-versed in conducting translational studies, developing biomarkers, and early clinical trials, ensuring a seamless transition from laboratory research to clinical applications.
Leadership Role at GSK
During her tenure at GlaxoSmithKline (GSK), Yolanda Sanchez held the position of Vice President and head of the Discovery Performance Unit for Respiratory. In this capacity, she led various research initiatives focused on respiratory diseases. Her role required strong leadership skills and a deep understanding of respiratory biology and pharmacology, contributing to the development of novel therapeutic approaches for respiratory conditions.
Expertise in Target and Pathway Identification and Validation
Yolanda Sanchez possesses significant expertise in target and pathway identification and validation. This area of research involves identifying potential biological targets for new therapies and validating their relevance in disease processes. Her skills ensure that the drug development pipeline is built on solid scientific foundations, ultimately leading to more effective and targeted treatments.
Lead-Optimization and Candidate Selection
In her career, Yolanda Sanchez has been deeply involved in lead-optimization and candidate selection. Lead-optimization refers to the process of refining chemical compounds to improve their efficacy and safety profiles. Candidate selection is the phase where the most promising compounds are chosen for further development. Sanchez's experience in these areas ensures that only the best candidates move forward in the drug development process, increasing the likelihood of successful therapeutic outcomes.